Combined Sulpiride, Olanzapine, and A Complex Isopathic Preparation for Delusional Disorder
Neurology - Research & Surgery · 2019
DOI: 10.33425/2641-4333.1012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurology - Research & Surgery, 2019. Verfasst von Maja Roje Novak.
Abstract (Originalsprache)
Introduction Delusional disorder is a poorly understood psychotic disorder characterized by one or more persistent delusions of persecution, grandiosity, or jealousy (among others) for over a month [1]. Although antipsychotic drugs, antidepressants, and mood stabilizers have all been used to treat delusional disorder with varying degrees of success [1,2], there is growing interest in managing patients with psychological (psychotherapy, CBT) and/or alternative therapies, as delusional disorder is sometimes resistant to drug therapy and considered difficult to treat. While there are no high-quality randomized trials on delusional disorder treatment, both firstand second-generation antipsychotics have been used with effect, with olanzapine – a second-generation antipsychotic thought to act via the dopamine and serotonin pathways [3] showing high recovery and partial improvement rates in affected individuals [1].
Zitieren
APA
Novak, M. R. (2019). Combined Sulpiride, Olanzapine, and A Complex Isopathic Preparation for Delusional Disorder. Neurology - Research & Surgery. https://doi.org/10.33425/2641-4333.1012
Vancouver
Novak MR. Combined Sulpiride, Olanzapine, and A Complex Isopathic Preparation for Delusional Disorder. Neurology - Research & Surgery. 2019. doi:10.33425/2641-4333.1012
BibTeX
@article{Novak2019,
author = {Novak, Maja Roje},
title = {Combined Sulpiride, Olanzapine, and A Complex Isopathic Preparation for Delusional Disorder},
journal = {Neurology - Research & Surgery},
year = {2019},
doi = {10.33425/2641-4333.1012}
}
EUVIMED